Abstract
This study aims to report on the clinical and laboratory picture and the disease course and outcome in patients having adult onset Still’s disease (AOSD), to briefly review existing literature on the subject, and to compare our findings with those previously reported. Results are reported for 28 patients with AOSD satisfying the preliminary criteria of Yamaguchi et al. seen in a teaching hospital over the last 10 years. A high percent of the patients with AOSD were women. The mean (+SD) age at disease onset was 27.8 (+8.4) years. We found fever in 100%, rash in 85%, arthritis in 64%, lymphadenopathy in 60%, splenomegaly in 57%, hepatomegaly in 35%, pleural effusion in 17.9%, and pericardial effusion in 3.6% of our patients. Leukocytosis was present in 96% of the patients, a normochromic, normocytic anemia in 54%, and an elevated erythrocyte sedimentation rate (ESR) in all. Serum ferritin levels were raised in 89% of the patients. The mean follow-up of the patients was 3.72 + 2.46 years. The mean delay in diagnosis was 7.32 + 18.0 months. The mean time to enter remission was 9.7 months. Self-limited, intermittent, and chronic disease course was seen in 14.3, 57.1, and 28.6% of patients, respectively. The outcome was good in about 89% of patients, and mortality was nil. No particular clinical or laboratory variable was found to predict the subsequent disease course and outcome in our patients. On comparing our data with important previous series, we found a higher percentage of women and of patients presenting in the age group 16–35 years, a lower frequency of arthritis and pericardial effusion, and some other notable differences. Importantly, the disease course was benign, probably as an outcome of heightened awareness and less diagnostic delay than in the past, allowing for early, aggressive, and appropriate treatment. It is concluded that AOSD is now a relatively benign disease if diagnosed early and treated appropriately.
Similar content being viewed by others
References
Still GF (1897) On a form of chronic joint disease in children. Med Chir Trans 80:47
Bywaters EG (1971) Still’s disease in the adult. Ann Rheum Dis 30:121–133
Al-Arfaj AS, Al-Saleh S (2001) Adult-onset Still’s disease in Saudi Arabia. Clin Rheumatol 20:197–200
Chen DY, Lan JL, Hsieh TY, Chen YH (2004) Clinical manifestations, disease course, and complications of adult-onset Still’s disease in Taiwan. J Formos Med Assoc 103:844–852
Ohta A, Yamaguchi M, Kaneoka H, Nagayoshi T, Hiida M (1987) Adult Still’s disease: review of 228 cases from the literature. J Rheumatol 14:1139–1146
Ohta A, Yamaguchi M, Tsunematsu T, Kasukawa R, Mizushima H, Kashiwagi H et al (1990) Adult Still’s disease: a multicenter survey of Japanese patients. J Rheumatol 17:1058–1063
Pay S, Turkcapar N, Kalyoncu M, Simsek I, Beyan E, Ertenli I et al (2006) A multicenter study of patients with adult-onset Still’s disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol 25(5):639–644
Pouchot J, Sampalis JS, Beaudet F, Carette S, Decary F, Salusinsky-Sternbach M et al (1991) Adult Still’s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 70:118–136
Uppal SS, Pande IR, Kumar A, Kailash S, Sekharan NG, Adya CM et al (1995) Adult onset Still’s disease in northern India: comparison with juvenile onset Still’s disease. Br J Rheumatol 34:429–434
Akritidis N, Sakkas LI (1995) Adult onset Still’s disease. 16 cases. Presse Med 24:1207–1208
Andres E, Kurtz JE, Perrin AE, Pflumio F, Ruellan A, Goichot B et al (2003) Retrospective monocentric study of 17 patients with adult Still’s disease, with special focus on liver abnormalities. Hepato-gastroenterology 50:192–195
Evensen KJ, Nossent HC (2006) Epidemiology and outcome of adult-onset Still’s disease in Northern Norway. Scand J Rheumatol 35:48–51
Garcia-Porrua C, Gonzalez-Gay MA, Crespo F, Gonzalez-Juanatey C (2000) Adult onset Still’s disease in Catalonia, Spain. J Rheumatol 27:280–281
Liu Y, Huang CB, Cai XH (1993) Adult onset Still’s disease: review of 50 cases and evaluation of diagnostic criteria. Zhonghua Nei Ke Za Zhi 32:603–606
Mert A, Ozaras R, Tabak F, Bilir M, Ozturk R, Ozdogan H et al (2003) Fever of unknown origin: a review of 20 patients with adult-onset Still’s disease. Clin Rheumatol 22:89–93
Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430
Kumari R, Uppal SS (2006) Prolonged remission in adult-onset Still’s disease with etanercept. Clin Rheumatol 25:106–108
Nara H, Mimori A (1999) Adult Still’s disease. Nippon Rinsho 57:384–387
van de Putte LB, Wouters JM (1991) Adult-onset Still’s disease. Bailliere’s Clin Rheumatol 5:263–275
Masson C, Le Loet X, Liote F, Dubost JJ, Boissier MC, Perroux-Goumy L et al (1996) Comparative study of 6 types of criteria in adult Still’s disease. J Rheumatol 23:495–497
Efthimiou P, Paik PK, Bielory L (2006) Diagnosis and management of adult onset Still’s disease. Ann Rheum Dis 65:564–572
Mok CC, Lau CS, Wong RW (1998) Clinical characteristics, treatment, and outcome of adult onset Still’s disease in southern Chinese. J Rheumatol 25:2345–2351
Wakai K, Ohta A, Tamakoshi A, Ohno Y, Kawamura T, Aoki R et al (1997) Estimated prevalence and incidence of adult Still’s disease: findings by a nationwide epidemiological survey in Japan. J Epidemiol 7:221–225
Akritidis N, Giannakakis I, Giouglis T (1996) Ferritin levels and response to treatment in patients with Adult Still’s disease. J Rheumatol 23:201–202
Akritidis N, Giannakakis Y, Sakkas L (1997) Very high serum ferritin levels in adult-onset Still’s disease. Br J Rheumatol 36:608–609
Nguyen KH, Weisman MH (1997) Severe sore throat as a presenting symptom of adult onset Still’s disease: a case series and review of the literature. J Rheumatol 24:592–597
Elkon KB, Hughes GR, Bywaters EG, Ryan PF, Inman RD, Bowley NB et al (1982) Adult-onset Still’s disease. Twenty-year followup and further studies of patients with active disease. Arthritis Rheum 25:647–654
Wouters JM, van de Putte LB (1986) Adult-onset Still’s disease; clinical and laboratory features, treatment and progress of 45 cases. Q J Med 61:1055–1065
Larson EB (1984) Adult Still’s disease. Evolution of a clinical syndrome and diagnosis, treatment, and follow-up of 17 patients. Medicine (Baltimore) 63:82–91
Nkoghe D, Demonty J, Leonard P, Nnegue S, Moutschen M, Kaye O (2002) Still’s disease in the adult. Rev Med Liege 57:213–219
Fitzgerald AA, Leclercq SA, Yan A, Homik JE, Dinarello CA (2005) Rapid responses to anakinra in patients with refractory adult-onset Still’s disease. Arthritis Rheum 52:1794–1803
Fautrel B, Sibilia J, Mariette X, Combe B (2005) Tumour necrosis factor alpha blocking agents in refractory adult Still’s disease: an observational study of 20 cases. Ann Rheum Dis 64:262–266
Kokkinos A, Iliopoulos A, Greka P, Efthymiou A, Katsilambros N, Sfikakis PP (2004) Successful treatment of refractory adult-onset Still’s disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol 23:45–49
Benucci M, Li GF, Del RA, Manfredi M (2005) Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still’s disease: the first case report. Clin Exp Rheumatol 23:733
Arlet JB, LE Thi HD, Marinho A, Amoura Z, Wechsler B, Papo T et al (2006) Reactive haemophagocytic syndrome in adult onset Still’s disease: report of 6 patients and review of the literature. Ann Rheum Dis (in press). DOI 10.1136/ard.2005.046904
Fietta P, Manganelli P (2003) The hemophagocytic syndrome (macrophage activation syndrome). Minerva Med 94:19–27
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uppal, S.S., Al-Mutairi, M., Hayat, S. et al. Ten years of clinical experience with adult onset Still’s disease: is the outcome improving?. Clin Rheumatol 26, 1055–1060 (2007). https://doi.org/10.1007/s10067-006-0440-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-006-0440-x